ATE254604T1 - Neue polycyclische aminopyridine als acetylcholinesterase hemmer, verfahren zur herstellung und deren verwendung - Google Patents

Neue polycyclische aminopyridine als acetylcholinesterase hemmer, verfahren zur herstellung und deren verwendung

Info

Publication number
ATE254604T1
ATE254604T1 AT96933447T AT96933447T ATE254604T1 AT E254604 T1 ATE254604 T1 AT E254604T1 AT 96933447 T AT96933447 T AT 96933447T AT 96933447 T AT96933447 T AT 96933447T AT E254604 T1 ATE254604 T1 AT E254604T1
Authority
AT
Austria
Prior art keywords
compounds
acetylcholinesterase inhibitors
general formula
aminopyridines
production
Prior art date
Application number
AT96933447T
Other languages
English (en)
Inventor
Pelayo Camps-Garcia
Lopez-Ibarra Die Munoz-Torrero
Romeu Diana Marina Gorbig
Lascorz Joan Contreras
Fornell Montserrat Simon
Cardoner Jordi Morral
Original Assignee
Medichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medichem Sa filed Critical Medichem Sa
Application granted granted Critical
Publication of ATE254604T1 publication Critical patent/ATE254604T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AT96933447T 1995-10-11 1996-10-11 Neue polycyclische aminopyridine als acetylcholinesterase hemmer, verfahren zur herstellung und deren verwendung ATE254604T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES09501965A ES2100129B1 (es) 1995-10-11 1995-10-11 Nuevos compuestos aminopiridinicos policiclicos inhibidores de acetilcolinesterasa, procedimiento para su preparacion y su utilizacion.
PCT/ES1996/000192 WO1997013754A1 (es) 1995-10-11 1996-10-11 Nuevos compuestos aminopiridinicos policiclicos inhibidores de acetilcolinesterasa, procedimiento para su preparacion y su utilizacion

Publications (1)

Publication Number Publication Date
ATE254604T1 true ATE254604T1 (de) 2003-12-15

Family

ID=8291815

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96933447T ATE254604T1 (de) 1995-10-11 1996-10-11 Neue polycyclische aminopyridine als acetylcholinesterase hemmer, verfahren zur herstellung und deren verwendung

Country Status (11)

Country Link
US (1) US5965569A (de)
EP (1) EP0796849B1 (de)
JP (1) JPH11500144A (de)
AT (1) ATE254604T1 (de)
AU (1) AU706760B2 (de)
BR (1) BR9606755A (de)
CA (1) CA2206446A1 (de)
DE (1) DE69630772T2 (de)
ES (2) ES2100129B1 (de)
NZ (1) NZ319617A (de)
WO (1) WO1997013754A1 (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1604653A1 (de) 1998-09-30 2005-12-14 Takeda Pharmaceutical Company Limited Acetylcholinesterase-Inhibitoren zur Verbesserung der Ausscheidungskraft der Harnblase
JP2004525109A (ja) 2001-02-15 2004-08-19 キング・ファーマシューティカルズ・インコーポレイティッド 安定化された甲状腺ホルモン医薬組成物、及びその製法
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
PL375552A1 (en) 2002-05-22 2005-11-28 Amgen Inc. Vanilloid receptor ligands and their medical applications
EP2270006A1 (de) 2002-08-08 2011-01-05 Amgen, Inc Pyridazin-Derivate zur Verwendung als Vanilloidrezeptorliganden
MY139645A (en) * 2004-02-11 2009-10-30 Amgen Inc Vanilloid receptor ligands and their use in treatments
JP2007522233A (ja) * 2004-02-11 2007-08-09 アムジエン・インコーポレーテツド バニロイド受容体リガンド及び治療におけるそれらの使用
WO2006071274A2 (en) * 2004-12-23 2006-07-06 Voyager Pharmaceutical Corporation Leuprolide acetate and acetylcholinesterase inhibitors or nmda receptor antagonists for the treatment of alzheimer’s disease
WO2006089311A1 (en) 2005-02-15 2006-08-24 Amgen Inc. Vanilloid receptor ligands and their use in treatments
WO2007056580A2 (en) * 2005-11-08 2007-05-18 Pharmadyn, Inc. Methods and compositions for treating diseases associated with pathogenic proteins
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
JP5523107B2 (ja) 2006-11-30 2014-06-18 プロビオドルグ エージー グルタミニルシクラーゼの新規阻害剤
EP2481408A3 (de) 2007-03-01 2013-01-09 Probiodrug AG Neue Verwendung von Inhibitoren der Glutaminyl Cyclase
WO2008128985A1 (en) 2007-04-18 2008-10-30 Probiodrug Ag Thiourea derivatives as glutaminyl cyclase inhibitors
PE20110565A1 (es) 2008-08-12 2011-09-02 Zinfandel Pharmaceuticals Inc Metodo de identificacion de factores de riesgo de la enfermedad
US8846315B2 (en) 2008-08-12 2014-09-30 Zinfandel Pharmaceuticals, Inc. Disease risk factors and methods of use
ES2740424T3 (es) 2009-03-13 2020-02-05 Agios Pharmaceuticals Inc Métodos y composiciones para trastornos relacionados con la proliferación celular
CA2758071C (en) 2009-04-06 2018-01-09 Agios Pharmaceuticals, Inc. Pyruvate kinase m2 modulators, therapeutic compositions and related methods of use
EP2448581B1 (de) 2009-06-29 2016-12-07 Agios Pharmaceuticals, Inc. Therapeutische zusammensetzungen und verfahren zu ihrer verwendung
SG10201403696UA (en) 2009-06-29 2014-10-30 Agios Pharmaceuticals Inc Therapeutic compounds and compositions
MX2012002993A (es) 2009-09-11 2012-04-19 Probiodrug Ag Derivados heterociclicos como inhibidores de ciclasa glutaminilo.
EP3064595B1 (de) 2009-10-21 2019-02-27 Agios Pharmaceuticals, Inc. Verfahren für zellproliferationsbedingte erkrankungen
US20110212928A1 (en) 2010-02-09 2011-09-01 The Johns Hopkins University Methods and compositions for improving cognitive function
JP6026284B2 (ja) 2010-03-03 2016-11-16 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤
US8269019B2 (en) 2010-03-10 2012-09-18 Probiodrug Ag Inhibitors
EP2377852A1 (de) * 2010-04-09 2011-10-19 Universite de Rouen Markierte Huprin-Derivate und ihre Verwendung für medizinische Bilderzeugung
EP2377853A1 (de) 2010-04-09 2011-10-19 Universite de Rouen 7,11-Methanocycloocta[b]chinolin-Derivate als Hochfunktionalisierbarer Acetylcholinesteraseinhibitoren
WO2011131748A2 (en) 2010-04-21 2011-10-27 Probiodrug Ag Novel inhibitors
CA2821975A1 (en) 2010-12-17 2012-06-21 Shunqi Yan N-(4-(azetidine-1-carbonyl)phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase m2 pkm2 modulators
WO2012088314A1 (en) 2010-12-21 2012-06-28 Agios Pharmaceuticals, Inc. Bicyclic pkm2 activators
TWI549947B (zh) 2010-12-29 2016-09-21 阿吉歐斯製藥公司 治療化合物及組成物
EA201391017A1 (ru) 2011-01-10 2014-04-30 Зинфандел Фармасьютикалз, Инк. Способы и готовые лекарственные формы для лечения болезни альцгеймера
ES2570167T3 (es) 2011-03-16 2016-05-17 Probiodrug Ag Derivados de benzimidazol como inhibidores de glutaminil ciclasa
AU2012250690B2 (en) 2011-05-03 2017-06-08 Agios Pharmaceuticals, Inc Pyruvate kinase activators for use in therapy
JP6272754B2 (ja) 2011-05-03 2018-01-31 アジオス ファーマシューティカルズ， インコーポレイテッド ピルビン酸キナーゼ活性化剤の使用方法
CN102827170A (zh) 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
CN102827073A (zh) 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
US9474779B2 (en) 2012-01-19 2016-10-25 Agios Pharmaceuticals, Inc. Therapeutically active compositions and their methods of use
US9238626B2 (en) * 2012-05-10 2016-01-19 Universitat De Barcelona Beta-amyloid-directed multitarget compounds for the treatment of alzheimer's disease
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
EP2968220B1 (de) 2013-03-15 2021-05-05 Agenebio, Inc. Verfahren und zusammensetzungen zur verbesserung von kognitiven funktionen
WO2015003360A2 (en) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
US10376510B2 (en) 2013-07-11 2019-08-13 Agios Pharmaceuticals, Inc. 2,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancer
WO2015003355A2 (en) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
WO2015010297A1 (en) 2013-07-25 2015-01-29 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
US9968595B2 (en) 2014-03-14 2018-05-15 Agios Pharmaceuticals, Inc. Pharmaceutical compositions of therapeutically active compounds
NZ738682A (en) 2015-05-22 2022-01-28 Agenebio Inc Extended release pharmaceutical compositions of levetiracetam
RS64777B1 (sr) 2015-06-11 2023-11-30 Agios Pharmaceuticals Inc Postupci upotrebe aktivatora piruvat kinaze
UA123401C2 (uk) 2015-10-15 2021-03-31 Аджиос Фармасьютікалз, Інк. Комбінована терапія для лікування злоякісних пухлин
DK3362066T3 (da) 2015-10-15 2021-11-22 Les Laboratoires Servier Sas Kombinationsterapi til behandling af maligniteter
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej
US10980788B2 (en) 2018-06-08 2021-04-20 Agios Pharmaceuticals, Inc. Therapy for treating malignancies
CN114848689B (zh) * 2022-05-12 2023-04-07 暨南大学 一种千层塔有效部位及其制备方法与在制备具有预防或治疗老年痴呆作用的药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695573A (en) * 1984-10-25 1987-09-22 Hoechst-Roussel Pharmaceuticals Inc. 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds
DK569087A (da) * 1986-10-31 1988-05-01 Sumitomo Pharma Quinolin-derivater, deres fremstilling og anvendelse
US4897400A (en) * 1987-02-13 1990-01-30 Hoeschst-Roussel Pharmaceuticals, Inc. 9-amino-1,4-ethano-1,2,3,4-tetrahydroacridine and related compounds useful for incresing the cholinergic function in a mammal
IL87861A0 (en) * 1987-10-05 1989-03-31 Pfizer 4-aminopyridine derivatives
DE3889302T2 (de) * 1987-12-03 1994-10-20 Mitsubishi Chem Ind 9-(Acylamino)tetrahydroacridinderivate und wahrnehmungssteigernde Mittel davon als aktiver Wirkstoff.
US5106979A (en) * 1989-02-21 1992-04-21 University Of Pittsburgh Method for the synthesis of huperzine A and analogs thereof and compounds useful therein
US5104880A (en) * 1991-05-01 1992-04-14 Mayo Foundation For Medical Education And Research Huperzine a analogs as acetylcholinesterase inhibitors
ES2042384B1 (es) * 1991-12-26 1994-06-01 Boehringer Ingelheim Espana Procedimiento para obtener derivados bis-piridinicos.

Also Published As

Publication number Publication date
JPH11500144A (ja) 1999-01-06
ES2100129B1 (es) 1998-02-16
EP0796849A1 (de) 1997-09-24
WO1997013754A1 (es) 1997-04-17
AU706760B2 (en) 1999-06-24
ES2211978T3 (es) 2004-07-16
BR9606755A (pt) 1998-01-06
AU7217696A (en) 1997-04-30
DE69630772T2 (de) 2004-09-30
DE69630772D1 (de) 2003-12-24
ES2100129A1 (es) 1997-06-01
CA2206446A1 (en) 1997-04-17
EP0796849B1 (de) 2003-11-19
NZ319617A (en) 2000-02-28
US5965569A (en) 1999-10-12

Similar Documents

Publication Publication Date Title
DE69630772D1 (de) Neue polycyclische aminopyridine als acetylcholinesterase hemmer, verfahren zur herstellung und deren verwendung
HU9302733D0 (en) Process for producing heterocyclic amine derivatives
DE69307208D1 (de) Verfahren zur Herstellung von Überzugfilmen aus Titanoxyd
ATE108453T1 (de) Benzopyridopiperidin, -piperidyliden und - piperazin-verbindungen, zusammensetzungen, methoden zur herstellung und verwendung.
HU9203161D0 (en) Method for producing substituted pyrimidines
HU913792D0 (en) Method for producing serotonine antagonists
PL300327A1 (en) Substituted cycolohexane derivatives, method of obtaining them and application of these compounds in treating diseases
NO903359D0 (no) Fremgangsmaate for fremstilling av 1,2,3,4-tetrahydro-9-akridinamin-derivater.
ATE201025T1 (de) Verfahren zur herstellung von cephalosporinen und zwischenprodukte in diesem verfahren
ATA278988A (de) Verfahren zur herstellung von 3-5-dimethyl-4methoxypyridinderivaten sowie neues zwischenprodukt hierfuer
DE50104557D1 (de) Neue beta-amyloid inhibitoren, verfahren zu deren herstellung und deren verwendung als arzneimittel
HUT54658A (en) Process for producing pyridine derivatives and pharmaceutical compositions comprising such compounds
DE3869028D1 (de) 1,2,5,6-tetrahydropyridinoxim-derivate, verfahren zu deren herstellung, deren verwendung als arzneimittel und diese enthaltende zusammensetzungen.
AU2522692A (en) Imidazol-1-yl methyl pyridine derivatives, processes for their production and their use as pharmaceuticals
NZ336111A (en) Substituted tetrahydropyridine derivatives, method of preparation and pharmaceutical compositions for treating memory disorders
DE3867986D1 (de) 1,2,5,6-tetrahydropyridin-3-carboxaldehydoxim-derivate, verfahren zu deren herstellung, deren verwendung als arzneimittel und diese enthaltende zusammensetzungen.
ATE36318T1 (de) Verfahren zur herstellung von azetidinderivaten und zwischenprodukte.
ES2009689A6 (es) Procedimiento para preparar derivados de 3-piperidina-carbaldehido-oxima.
ATE270287T1 (de) 2,3-dihydro-1h-isoindolderivate, verfahren zu ihrer herstellung und ihre verwendung als hemmer der serotoninwiederaufnahme
SG43065A1 (en) Pyridine derivatives
ATE234820T1 (de) Aminoalkyloxime, verfahren zur dessen herstellung,ihre verwendung als medikamente und zwischenprodukte
DE69810340D1 (de) Naphtho-imidazo(1,2-a)pyridin derivate, deren herstellung und deren verwendung in der behandlung von störungen des zentralnervensystems
ATE247641T1 (de) Pyridin-zwischenprodukte, verwendbar zur herstellung von beta-adrenergischen rezeptor- agonisten
HUT58715A (en) Process for producing 6-(substituted amino-propionyl)-phorscholine derivatives
DE59606725D1 (de) Substituierte phenylamidine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties